The Medical Case for the Development of an Intravenous Statin Formulation – Beyond Ischemic Stroke

Publisher： Karger

E-ISSN： 1421-9786|25|6|593-594

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.25, Iss.6, 2008-05, pp. : 593-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Perfusion Computed Tomography-Guided Intravenous Thrombolysis for Acute Ischemic Stroke beyond 4.5 Hours: A Case-Control Study

By  

Cerebrovascular Diseases, Vol. 34, Iss. 1, 2012-06 ,pp. : 31-37

Karger

Access to resources Recommend Favorite

Impact of Increased Early Statin Administration on Ischemic Stroke Outcomes: A Multicenter Electronic Medical Record Intervention

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 8, 2016-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Effect of Statin Pretreatment on Infarct Volume in Ischemic Stroke

By  

Neuroepidemiology, Vol. 31, Iss. 1, 2008-06 ,pp. : 48-56

Karger

Access to resources Recommend Favorite

Safety and Feasibility of a Lower Dose Intravenous TPA Therapy for Ischemic Stroke beyond the First Three Hours

By  

Cerebrovascular Diseases, Vol. 19, Iss. 4, 2005-04 ,pp. : 260-266

Karger

Access to resources Recommend Favorite

Symptomatic Intracranial Hemorrhage following Intravenous Thrombolysis for Acute Ischemic Stroke: A Critical Review of Case Definitions

By  

Cerebrovascular Diseases, Vol. 34, Iss. 2, 2012-08 ,pp. : 106-114

Karger

Access to resources Recommend Favorite